Bernd R. Seizinger

Insider Reports History

Location
535 Boylston Street, Boston, MA
Signature
/s/ John Hamill, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Bernd R. Seizinger:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Aprea Therapeutics, Inc. Director Common Stock 45.8K $74.2K $1.62 Jun 5, 2025 Direct
Aptose Biosciences Inc. Director Common Shares 17K $53.4K $3.14 Sep 22, 2023 Direct
Aprea Therapeutics, Inc. Director Stock Options (Right to Buy) 4.19K Jun 20, 2024 Direct
Aprea Therapeutics, Inc. Director Stock Options (Right to Buy) 4.19K Jun 5, 2025 Direct
Aptose Biosciences Inc. Director Director Stock Option (Right to Buy) 3.33K Feb 5, 2024 Direct

Insider Reports Filed by Bernd R. Seizinger

Symbol Company Period Transactions Value $ Form Type Date Filed Role
APRE Aprea Therapeutics, Inc. Jun 5, 2025 2 $0 4 Jun 9, 2025 Director
APRE Aprea Therapeutics, Inc. Oct 11, 2024 1 $26.8K 4 Oct 15, 2024 Director
APRE Aprea Therapeutics, Inc. Jun 20, 2024 2 $0 4 Jun 21, 2024 Director
APRE Aprea Therapeutics, Inc. Mar 13, 2024 3 $50K 4 Mar 14, 2024 Director
APTO Aptose Biosciences Inc. Feb 5, 2024 1 $0 4 Feb 7, 2024 Director
APTO Aptose Biosciences Inc. Sep 22, 2023 1 $53.4K 4 Sep 25, 2023 Director
APRE Aprea Therapeutics, Inc. Aug 23, 2023 2 $0 4 Aug 24, 2023 Director
APRE Aprea Therapeutics, Inc. Jun 6, 2023 2 $37K 4 Jun 8, 2023 Director
APTO Aptose Biosciences Inc. Jan 19, 2023 1 $0 4 Jan 23, 2023 Director
APTO Aptose Biosciences Inc. Sep 14, 2022 1 $0 4 Sep 16, 2022 Director
APTO Aptose Biosciences Inc. Sep 13, 2022 0 $0 3 Sep 16, 2022 Director
APRE Aprea Therapeutics, Inc. Jul 28, 2022 2 $0 4 Aug 1, 2022 Director
APRE Aprea Therapeutics, Inc. May 18, 2022 1 $35.5K 4 May 19, 2022 Director
APRE Aprea Therapeutics, Inc. Jun 30, 2021 2 $0 4 Jul 1, 2021 Director